Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Michael Licina, MD, is a Staff Anesthesiologist and Vice Chair of Operations in the Department of Cardiothoracic Anesthesia, Anesthesiology Institute at Cleveland Clinic. He is board-certified in anesthesiology, perioperative transesophageal echocardiography and critical care medicine. Dr. Licina has a special interest in cardiothoracic anesthesiology, clinical research related to the assessment and treatment of ventricular dysfunction, intraoperative echocardiography, quality assessment and improvement, and resident education.
A native of Pennsylvania, Dr. Licina attended the University of Pittsburgh, graduating summa cum laude with a degree in chemistry/biochemistry. Following his undergraduate work, he continued at the University of Pittsburgh for his medical degree, where he won the Charles Guthrie Award in Physiology. He took his internship in internal medicine and a residency in anesthesia at the Naval Hospital in Bethesda, Maryland, where he became Chief Resident.
This clinical training was followed by fellowships in cardiothoracic anesthesia from the Naval Hospital and from Emory University in Atlanta. Dr. Licina became a Staff Anesthesiologist at the Naval Hospital, and Assistant Professor of Anesthesiology at the Uniformed Services of Health Sciences, as part of his military obligation. He served for 8 years of active duty in various roles.
This was followed by a fellowship in echocardiography from Cleveland Clinic. He was appointed to Cleveland Clinic in 1988 as a Staff Anesthesiologist in the Department of Cardiothoracic Anesthesia. Dr. Licina was an Associate Professor of Anesthesiology at the Cleveland Clinic Foundation Health Sciences Center at the Ohio State University. Dr. Licina has been active at the Cleveland Clinic Lerner College of Medicine as a PBL instructor since it was founded. He is Diplomate of the American Board of Anesthesiology.
Dr. Licina served in Operation Desert Shield/Desert Storm and was honorably discharged from the Navy with the rank of Commander. He is a senior examiner for the American Board of Anesthesiology and sat on the Intraoperative TEE Council of the American Society of Echocardiography.
His current clinical research is part of a pilot, multicenter randomized study to evaluate nesiritide infusion, post-induction anesthesia, to manage coronary artery bypass graft patients who require cardiopulmonary bypass surgery. Dr. Licina has been invited to present his clinical experiences and research to medical symposia and conferences nationally and internationally. He has published articles and abstracts related to his specialty interests in leading medical journals. He is author or co-author of several chapters in medical textbooks on cardiac anesthesia, prosthetic valve function, and intraoperative transesophageal echocardiography.
Dr. Licina is a member of the American Society of Anesthesiologists, the International Anesthesia Research Society, the Society of Cardiovascular Anesthesia, the American Society of Echocardiography, the Ohio Society of Anesthesiologists and the Cleveland Society of Anesthesiologists.
Dr Licina has been very active in community service. He has been involved with the Greater Cleveland Council of the Boy Scouts of America for the last 11 years in a troop,district and council level.
assessment and treatment for ventricular dysfunction, cardiothoracic anesthesia, cardiothoracic anesthesiology, clinical research, fellow and resident education, intraoperative echocardiography, intraoperative TEE, intraoperative transesophageal echocardiography, quality assessment and improvement, resident teaching
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/5/2013, Dr. Licina has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.